Nanoparticle Modification of Human Adipose-derived Mesenchymal Stem Cells for Brain Cancer and Other Neurological Diseases

Case ID:
C13152
Human Adipose-derived Mesenchymal Stem Cells can be engineered to synthesize and release anti-tumor proteins and therefore can be used as “Trojan Horses”. The inventors have created a novel technology which encompasses a solution containing biodegradable, polymeric nanoparticles that is combined with Freshly-extracted Adipose Tissue (F.A.T.) (from a patient, autologous cells). This technology non-virally engineers the F.A.T. including the primary hAMSCs contained within the F.A.T to secrete anti-cancer proteins while maintaining the cells' ability to migrate toward tumor cells. For future clinical application, the nanoparticles could be added ex vivo to hAMSCs obtained from patient fat after culturing for a few days and then the autologous cells administered IV as a treatment. Alternatively, the nanoparticle solution can be added to F.A.T. with the resulting mixture re-administered during surgery, without the cells being processed. This technology is more easily translatable than cell therapy approaches that require cell culturing and many FDA regulations. This is a revolutionary new way of treating patients with brain cancer and facilitating personalized medicine.
Patent Information:
Title App Type Country Serial No. Patent No. File Date Issued Date Expire Date Patent Status
Nanoparticle Modification of Human Adipose-derived Mesenchymal Stem Cells for Treating Brain Cancer and Other Neurological Diseases DIV: Divisional United States 16/600,268 11,547,729 10/11/2019 1/10/2023 3/23/2037 Granted
Nanoparticle Modification of Human Adipose-derived Mesenchymal Stem Cells for Brain Cancer and Other Neurological Diseases CON: Continuation United States 18/075,940   12/6/2022     Pending
Inventors:
Category(s):
Get custom alerts for techs in these categories/from these inventors:
For Information, Contact:
Nakisha Holder
nickki@jhu.edu
410-614-0300
Save This Technology:
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum